Marina Basina

Endocrinologist

Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism

Endocrinology Clinic

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6961
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Internal Medicine, American Board of Internal Medicine (2013)

Board Certification: Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine (2003)

Residency: UCLA/West Los Angeles VAMC (2001) CA

Fellowship: Stanford University School of Medicine (2003) CA

Internship: UCLA/West Los Angeles VAMC (1999) CA

Medical Education: Second Moscow Medicial University (1987) Russia

Board Certification, Board of Internal Medicine, Internal Medicine (2001)

Board Certification, Board of Internal Medicine, Endocrinology and Diabetes (2003)

Fellowship, Stanford University, Endocrinology (2003)

Residency, UCLA/West LA VA, Internal Medicine (2001)

Internship, UCLA/West LA VA, Medicine (1999)

MD, Moscow Medical School, Russia, Medicine (1987)

Honors & Awards

House staff Award for Demonstrating Excellence in Clinical Teaching, Kaiser Permanente Internal Medicine Residency Program (2004)

Top Recommended Doctor, Bay Area Consumer Report Magazine (2007)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Successful long-term treatment of Cushing disease with mifepristone (RU486).
Basina, M., Liu, H., Hoffman, A. R., & Feldman, D. (2012). Successful long-term treatment of Cushing disease with mifepristone (RU486). Endocrine practice , 18(5), e114-20.

Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes - Comparison of moderate fat versus carbohydrate reductions
McLaughlin, T., Carter, S., Lamendola, C., Abbasi, F., Schaaf, P., & Reaven, G. (2007). Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes - Comparison of moderate fat versus carbohydrate reductions. DIABETES CARE, 30(7), 1877-1879.

Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults
McLaughlin, T., Carter, S., Lamendola, C., Abbasi, F., Yee, G., & Reaven, G. (2006). Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. AMERICAN JOURNAL OF CLINICAL NUTRITION, 84(4), 813-821.

Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome
Cataldo, N. A., Abbasi, F., McLaughlin, T. L., Basina, M., Fechner, P. Y., & Reaven, G. M. (2006). Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. HUMAN REPRODUCTION, 21(1), 109-120.

Effectiveness of Diabetes Management: is Improvement Feasible?
Marina Basina, & Frederick B Kraemer. (2002). Effectiveness of Diabetes Management: is Improvement Feasible?. American Journal of Medicine, 112(8).

Utilization of Thyrogen.
Weisler, S., Basina, M, & Hershman JM. (2001). Utilization of Thyrogen. Thyroid, 11(11).